<SEC-DOCUMENT>0000899243-22-024031.txt : 20220624
<SEC-HEADER>0000899243-22-024031.hdr.sgml : 20220624
<ACCEPTANCE-DATETIME>20220624164845
ACCESSION NUMBER:		0000899243-22-024031
CONFORMED SUBMISSION TYPE:	3/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220324
FILED AS OF DATE:		20220624
DATE AS OF CHANGE:		20220624

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Global Health Technology Fund, L.P.
		CENTRAL INDEX KEY:			0001783165
		STATE OF INCORPORATION:			E9

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040720

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Global Health Technology Fund DE, L.P.
		CENTRAL INDEX KEY:			0001799812
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040719

	BUSINESS ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		C/O ADJUVANT CAPITAL, L.P.
		STREET 2:		501 FIFTH AVENUE, SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Capital GP, L.P.
		CENTRAL INDEX KEY:			0001935100
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040718

	BUSINESS ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Adjuvant Capital Management, LLC
		CENTRAL INDEX KEY:			0001935084
		STATE OF INCORPORATION:			DE

	FILING VALUES:
		FORM TYPE:		3/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41331
		FILM NUMBER:		221040717

	BUSINESS ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017
		BUSINESS PHONE:		917-334-0724

	MAIL ADDRESS:	
		STREET 1:		501 FIFTH AVENUE
		STREET 2:		SUITE 1404
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10017

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AN2 Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001880438
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				820606654
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027
		BUSINESS PHONE:		(650) 331-9090

	MAIL ADDRESS:	
		STREET 1:		1800 EL CAMINO REAL, SUITE D
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94027
</SEC-HEADER>
<DOCUMENT>
<TYPE>3/A
<SEQUENCE>1
<FILENAME>doc3a.xml
<DESCRIPTION>FORM 3/A SUBMISSION
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3/A</documentType>

    <periodOfReport>2022-03-24</periodOfReport>

    <dateOfOriginalSubmission>2022-03-24</dateOfOriginalSubmission>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001880438</issuerCik>
        <issuerName>AN2 Therapeutics, Inc.</issuerName>
        <issuerTradingSymbol>ANTX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001783165</rptOwnerCik>
            <rptOwnerName>Adjuvant Global Health Technology Fund, L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ADJUVANT CAPITAL, L.P.</rptOwnerStreet1>
            <rptOwnerStreet2>501 FIFTH AVENUE, SUITE 1404</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001799812</rptOwnerCik>
            <rptOwnerName>Adjuvant Global Health Technology Fund DE, L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ADJUVANT CAPITAL, L.P.</rptOwnerStreet1>
            <rptOwnerStreet2>501 FIFTH AVENUE, SUITE 1404</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001935100</rptOwnerCik>
            <rptOwnerName>Adjuvant Capital GP, L.P.</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ADJUVANT CAPITAL, L.P.</rptOwnerStreet1>
            <rptOwnerStreet2>501 FIFTH AVENUE, SUITE 1404</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001935084</rptOwnerCik>
            <rptOwnerName>Adjuvant Capital Management, LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ADJUVANT CAPITAL, L.P.</rptOwnerStreet1>
            <rptOwnerStreet2>501 FIFTH AVENUE, SUITE 1404</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10017</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Series A Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>1651636</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series A Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>312415</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Adjuvant Global Health Technology Fund DE, L.P.</value>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>392433</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Series B Convertible Preferred Stock</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F1"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>74230</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>By Adjuvant Global Health Technology Fund DE, L.P.</value>
                    <footnoteId id="F3"/>
                </natureOfOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Each share of Preferred Stock automatically converts on a one-for-one basis into Common Stock immediately prior to the closing of the Issuer's initial public offering (the &quot;IPO&quot;), for no additional consideration. The shares of Preferred Stock have no expiration date.</footnote>
        <footnote id="F2">Shares held directly by Adjuvant Global Health Technology Fund, L.P. (&quot;AGHT Fund&quot;). The sole general partner of AGHT Fund is Adjuvant Capital GP, L.P. (&quot;AC GP&quot;) and the sole general partner of AC GP is Adjuvant Capital Management, L.L.C. (&quot;AC MGMT&quot;). Kabeer Aziz, a member of the Issuer's board of directors, is a Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.</footnote>
        <footnote id="F3">Shares held directly by Adjuvant Global Health Technology Fund DE, L.P. (&quot;AGHT Fund DE&quot;) . The sole general partner of AGHT Fund DE is AC GP and the sole general partner of AC GP is the AC MGMT. Kabeer Aziz, a member of the Issuer's board of directors, is a Secretary of AC MGMT, and may be deemed to share voting and dispositive power over the securities held by such entities. Each such person and entity disclaims beneficial ownership of the securities, except to the extent of such person's or entity's pecuniary interest in such securities.</footnote>
    </footnotes>

    <remarks>This Form 3 amendment is being filed to add AGHT Fund and AC MGMT as reporting persons, each of which was inadvertently omitted from the initial Form 3, and to clarify that AGHT Funds holds securities of  the Issuer directly.</remarks>

    <ownerSignature>
        <signatureName>Adjuvant Global Health Technology Fund, L.P.,By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner By: Kabeer Aziz, Secretary /s/ Kabeer Aziz</signatureName>
        <signatureDate>2022-06-24</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Adjuvant Global Health Technology Fund DE, L.P., By: Adjuvant Capital GP, L.P., its sole general partner, By: Adjuvant Capital Management, L.L.C., its sole general partner By: Kabeer Aziz, Secretary /s/ Kabeer Aziz</signatureName>
        <signatureDate>2022-06-24</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Adjuvant Capital GP, L.P. By: Adjuvant Capital Management, L.L.C., its sole general partner, By: Kabeer Aziz, Secretary /s/ Kabeer Aziz</signatureName>
        <signatureDate>2022-06-24</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Adjuvant Capital Management, L.L.C. By: Kabeer Aziz, Secretary /s/ Kabeer Aziz</signatureName>
        <signatureDate>2022-06-24</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
